Comp Set VINEETLAB BIOFILCHEM× MANGALAM× LASA× + KREBSBIO + ALPA + BALPHARMA + ORTINGLOBE + NATCAPSUQ + NECLIFE + AAREYDRUGS + MEDICAMEQ + MEDICO
In ₹ Crore except Per Share
Latest Annual
VINEETLAB
FY26
BIOFILCHEM
FY26
MANGALAM
FY26
LASA
FY26
Peer
Average
Valuation — at last close P/E 36.06× ◆ 17.11×— — 17.11× +111% P/B 1.52× 2.21× ◆ 0.45×0.47× 1.04× +46% EV/EBITDA 11.50× 72.85× ◆ -10.12×-1.14× 20.53× -44% Market Cap ₹69.3 Cr ₹47.6 Cr ₹46.1 Cr ₹23.4 Cr ₹39 Cr +77% Growth Revenue CAGR 3Y -34.59% ◆ -1.85%— -42.11% -21.98% -57% Revenue CAGR 5Y -24.58% ◆ -4.50%— -34.11% -19.30% -27% Net Income CAGR 3Y 8.59% ◆ 70.67%— — 70.67% -88% Revenue YoY (latest Q) 39.66% ◆ 91.99%-0.40% -93.87% -0.76% +5318% Net Income YoY (latest Q) ◆ 274.84%-95.47% 44.64% 83.05% 10.74% +2459% Profitability EBITDA Margin ◆ 14.27%2.29% -6.42% -112.98% -39.04% +137% Net Income Margin 2.70% ◆ 9.81%-19.13% -135.60% -48.31% +106% Return on Common Equity 5.32% ◆ 13.81%-35.23% -51.13% -24.18% +122% Return on Capital Employed ◆ 15.62%1.83% -22.60% -51.42% -24.06% +165% Return on Assets 1.46% ◆ 5.94%-13.03% -40.63% -15.91% +109% Credit & Quality Total Debt/Equity 0.99× ◆ 0.14×1.02× 0.20× 0.45× +118% Interest Coverage 1.24× ◆ 37.37×-2.04× -89.13× -17.93× +107% Scale — latest FY Revenue / Total Income ₹59.4 Cr ₹28.4 Cr ₹232 Cr ₹25.1 Cr ₹95.2 Cr -38% Net Income ₹1.6 Cr ₹2.8 Cr −₹44.4 Cr −₹34.1 Cr −₹25.2 Cr +106% Total Assets ₹125 Cr ₹42.8 Cr ₹315 Cr ₹66.3 Cr ₹141 Cr -12% EPS ₹1 ₹1.71 ₹-28.05 ₹-6.8 ₹-11.05 +109% Book Value per Share ₹23.74 ₹13.25 ₹65.11 ₹9.9 ₹29.42 -19%
◆ best value in the comp set per metric · Δ = subject vs average of the other companies.
« ‹ › » Latest: FY26 · Standalone CHART » ALPHA AI » COMP » FA Financial Analysis · alphave
Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 95% .
